rs118192178
From SNPedia
| Orientation | plus |
| Stabilized | plus |
| Geno | Mag | Summary |
|---|---|---|
| (C;C) | 0 | common in clinvar |
| (C;G) | 3 | malignant hyperthermia |
| (C;T) | 3 | malignant hyperthermia |
| Make rs118192178(T;T) |
| Reference | GRCh38 38.1/141 |
| Chromosome | 19 |
| Position | 38500898 |
| Gene | RYR1 |
| is a | snp |
| is | mentioned by |
| dbSNP | rs118192178 |
| dbSNP (classic) | rs118192178 |
| ClinGen | rs118192178 |
| ebi | rs118192178 |
| HLI | rs118192178 |
| Exac | rs118192178 |
| Gnomad | rs118192178 |
| Varsome | rs118192178 |
| LitVar | rs118192178 |
| Map | rs118192178 |
| PheGenI | rs118192178 |
| Biobank | rs118192178 |
| 1000 genomes | rs118192178 |
| hgdp | rs118192178 |
| ensembl | rs118192178 |
| geneview | rs118192178 |
| scholar | rs118192178 |
| rs118192178 | |
| pharmgkb | rs118192178 |
| gwascentral | rs118192178 |
| openSNP | rs118192178 |
| 23andMe | rs118192178 |
| SNPshot | rs118192178 |
| SNPdbe | rs118192178 |
| MSV3d | rs118192178 |
| GWAS Ctlg | rs118192178 |
| Max Magnitude | 3 |
aka c.7522C>T (p.Arg2508Cys or R2508C) and also c.7522C>G (p.Arg2508Gly or R2508G), both of which are considered pathogenic in either ClinVar and/or the RYR1-based database
23andMe name for c.7522C>T: i6017673
| ClinVar | |
|---|---|
| Risk | rs118192178(G;G) rs118192178(T;T) |
| Alt | rs118192178(G;G) rs118192178(T;T) |
| Reference | Rs118192178(C;C) |
| Significance | Other |
| Disease | not provided Central core disease Malignant hyperthermia |
| Variation | info |
| Gene | RYR1 |
| CLNDBN | not provided Central core disease Malignant hyperthermia, susceptibility to, 1 |
| Reversed | 0 |
| HGVS | NC_000019.9:g.38991538C>G; NC_000019.9:g.38991538C>T |
| CLNSRC | UniProtKB (protein) |
| CLNACC | RCV000119717.1, RCV000056228.2, RCV000119718.1, RCV000178618.1, |
[PMID 12565913] Principal mutation hotspot for central core disease and related myopathies in the C-terminal transmembrane region of the RYR1 gene.
[PMID 16621918] Central core disease is due to RYR1 mutations in more than 90% of patients.
[PMID 16732084] Malignant hyperthermia in Japan: mutation screening of the entire ryanodine receptor type 1 gene coding region by direct sequencing.
[PMID 16917943] Mutations in RYR1 in malignant hyperthermia and central core disease.
